Open-Label Treatment Extension of Protocol MNTX 302

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01367613
Recruitment Status : Completed
First Posted : June 7, 2011
Last Update Posted : July 19, 2011
Information provided by:
Valeant Pharmaceuticals International, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2006
  Study Completion Date : January 2006